Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In a series of 154 patients taken to surgery for isolated hepatic perfusion to treat unresectable liver metastases, the hepatic response rate was 50% and the median progression-free and overall survival was 7.4 and 24.8 months, respectively.

Isolated Hepatic Perfusion for Colorectal Liver Metastases